The Roles of MicroRNA-133 in Gynecological Tumors

Overview

Journal Gynecol Minim Invasive Ther

Date 2022 Jun 24

PMID 35746911

Authors

Yang Zhou

Zhongping Cheng

Affiliations

Soon will be listed here.

Abstract

MicroRNAs are noncoding small RNAs that regulate gene expression posttranscriptionally. They act as a key role not only in the body development but also in many human diseases, including malignant tumors. With evidence of the complex role of miR-133 during gynecological malignancies initiation and progression are gradually emerging, miR-133 shows suppressive function by inhibiting tumor proliferation, invasion, and metastasis or acts as an oncogene by promoting tumor initiation, growth and invasion, depending on different tumor types and differentiation. In this review, we summarize the role and related regulatory methods of miR-133 in gynecological cancers. Moreover, then, we analyze and clarify the research status of other microRNAs acting on similar genes and pathways in gynecological tumors and look forward to their future research directions. This review may provide new expectations for applying miR-133 as diagnostic and prognostic biomarkers in gynecological tumors.

Citing Articles

The Progression and Prospects of the Gene Expression Profiling in Ovarian Epithelial Cancer.

Srinivasamurthy B, Ramamoorthi S Gynecol Minim Invasive Ther. 2024; 13(3):141-145.

PMID: 39184260 PMC: 11343359. DOI: 10.4103/gmit.gmit_13_23.

Surgical Site Infection in Laparoscopic Hysterectomy versus Abdominal Hysterectomy in Gynecological Disease(s): An Overview.

Agarwal M, Sinha S, Haripriya H, Kokkayil P, Singh S Gynecol Minim Invasive Ther. 2024; 13(1):25-29.

PMID: 38487611 PMC: 10936718. DOI: 10.4103/gmit.gmit_56_23.

References

Zhang L, Chen Y, Jia J, Zhu X, He Y, Wu L . MiR-27a promotes EMT in ovarian cancer through active Wnt/????-catenin signalling by targeting FOXO1. Cancer Biomark. 2019; 24(1):31-42. DOI: 10.3233/CBM-181229. View

Fujiwara T, Katsuda T, Hagiwara K, Kosaka N, Yoshioka Y, Takahashi R . Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells. 2014; 32(4):959-73. DOI: 10.1002/stem.1618. View

Liu X, Li G . MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor. Int J Clin Exp Pathol. 2015; 8(9):10605-14. PMC: 4637585. View

Chen X, Zhang Z, Ma Y, Su H, Xie P, Ran J . LINC02381 Promoted Cell Viability and Migration via Targeting miR-133b in Cervical Cancer Cells. Cancer Manag Res. 2020; 12:3971-3979. PMC: 7261661. DOI: 10.2147/CMAR.S237285. View

Zhang R, Shi H, Ren F, Feng W, Cao Y, Li G . MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways. J Exp Clin Cancer Res. 2019; 38(1):494. PMC: 6916056. DOI: 10.1186/s13046-019-1494-3. View

Rodriguez A, Griffiths-Jones S, Ashurst J, Bradley A . Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004; 14(10A):1902-10. PMC: 524413. DOI: 10.1101/gr.2722704. View

Yang Q, Yu Y, Sun Z, Pan Y . Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. Biomed Pharmacother. 2018; 106:61-67. DOI: 10.1016/j.biopha.2018.06.112. View

Yang L, Hou J, Cui X, Suo L, Lv Y . MiR-133b regulates the expression of CTGF in epithelial-mesenchymal transition of ovarian cancer. Eur Rev Med Pharmacol Sci. 2017; 21(24):5602-5609. DOI: 10.26355/eurrev_201712_14001. View

Szafranska A, Davison T, John J, Cannon T, Sipos B, Maghnouj A . MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007; 26(30):4442-52. DOI: 10.1038/sj.onc.1210228. View

10.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

11.

Sempere L, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V . Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004; 5(3):R13. PMC: 395763. DOI: 10.1186/gb-2004-5-3-r13. View

12.

Luo J, Zhou J, Cheng Q, Zhou C, Ding Z . Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression. Oncol Lett. 2014; 7(4):1043-1048. PMC: 3961467. DOI: 10.3892/ol.2014.1841. View

13.

Guo J, Xia B, Meng F, Lou G . miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol. 2013; 35(2):1557-64. DOI: 10.1007/s13277-013-1215-z. View

14.

Yamamoto N, Nishikawa R, Chiyomaru T, Goto Y, Fukumoto I, Usui H . The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer. Int J Oncol. 2015; 47(1):325-34. DOI: 10.3892/ijo.2015.2986. View

15.

Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L . A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog. 2010; 6(6):e1000967. PMC: 2891821. DOI: 10.1371/journal.ppat.1000967. View

16.

Zhou Y, Jin Z, Wang C . Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p. Biomed Pharmacother. 2019; 120:109449. DOI: 10.1016/j.biopha.2019.109449. View

17.

Wu R, Ali S, Bandyopadhyay S, Alosh B, Hayek K, Daaboul M . Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis. J Cancer Sci Ther. 2016; 7(7):258-265. PMC: 4725315. DOI: 10.4172/1948-5956.1000359. View

18.

Padmanabhan R, Hendry I, Knapp J, Shuai B, Hendry W . Altered microRNA expression patterns during the initiation and promotion stages of neonatal diethylstilbestrol-induced dysplasia/neoplasia in the hamster (Mesocricetus auratus) uterus. Cell Biol Toxicol. 2017; 33(5):483-500. PMC: 5587358. DOI: 10.1007/s10565-017-9389-6. View

19.

Tay Y, Zhang J, Thomson A, Lim B, Rigoutsos I . MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008; 455(7216):1124-8. DOI: 10.1038/nature07299. View

20.

Zhang X, Li Z, Xuan Z, Xu P, Wang W, Chen Z . Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis. J Exp Clin Cancer Res. 2018; 37(1):320. PMC: 6302516. DOI: 10.1186/s13046-018-0993-y. View